EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Enhancement of carbohydrate metabolism by probiotic and prebiotic intake promotes short-chain fatty acid production in the gut microbiome: a randomized, double-blind, placebo-controlled crossover trial

Yuhei Baba iD, Daisuke Tsuge, Ryo Aoki

Bioscience, Biotechnology, and Biochemistry · 23.07.2025 · 89 (8) · 1191-1202

DOI: 10.1093/bbb/zbaf071 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, online erschienen am 14.05.2025. Verfasst von Yuhei Baba und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dairy Business Division, Ezaki Glico Co., Ltd., Osaka, Japan. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Fatty Acids, Volatile, Prebiotics, Probiotics. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Short-chain fatty acids (SCFAs) are thought to be a key factor in the health benefits of prebiotics and probiotics. This study investigated the effect of Bifidobacterium animalis subsp. lactis GCL2505 and inulin (BL + IN) on fecal SCFAs and gut microbial composition and function. A placebo-controlled, randomized, double-blind, crossover study was conducted with 120 participants. Two weeks of BL + IN intake significantly increased acetate, propionate, and butyrate concentrations and Bifidobacterium abundance compared to placebo. Functional analysis of the gut metagenome showed enrichment of genes associated with carbohydrate and amino acid metabolism, suggesting an enhanced capacity for SCFA production. A responder was defined as a participant with increased fecal SCFAs after BL + IN consumption. Responder metagenomes exhibited greater enrichment of genes involved in SCFA production and carbohydrate metabolism. In conclusion, short-term BL + IN ingestion may benefit healthy adults by increasing fecal SCFAs through influencing the composition and functional activation of SCFA-associated pathways in the gut microbiome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeFatty Acids, VolatilePrebioticsProbioticsCarbohydrate MetabolismHumansDouble-Blind MethodCross-Over StudiesMaleAdultFemaleFecesInulinYoung AdultMiddle Aged

Stichwörter der Autor:innen

Bifidobacteriumgut microbiomeinulinmetagenomeshort-chain fatty acid

Substanzen

Fatty Acids, VolatilePrebioticsInulin

Autor:innen und Institutionen

  • Dairy Business Division, Ezaki Glico Co., Ltd., Osaka, Japan.
  • Shinagawa Season Terrace Health Care Clinic, Tokyo, Japan.
  • Mechanism-based Research Laboratory, Ezaki Glico Co., Ltd., Osaka, Japan.

ORCID-Profile: Yuhei Baba

Zitieren

APA

Baba, Y., Tsuge, D., & Aoki, R. (2025). Enhancement of carbohydrate metabolism by probiotic and prebiotic intake promotes short-chain fatty acid production in the gut microbiome: a randomized, double-blind, placebo-controlled crossover trial. Bioscience, Biotechnology, and Biochemistry, 89(8), 1191-1202. https://doi.org/10.1093/bbb/zbaf071

Vancouver

Baba Y, Tsuge D, Aoki R. Enhancement of carbohydrate metabolism by probiotic and prebiotic intake promotes short-chain fatty acid production in the gut microbiome: a randomized, double-blind, placebo-controlled crossover trial. Bioscience, Biotechnology, and Biochemistry. 2025;89(8):1191-1202. doi:10.1093/bbb/zbaf071

BibTeX
@article{Baba2025,
  author = {Baba, Yuhei and Tsuge, Daisuke and Aoki, Ryo},
  title = {Enhancement of carbohydrate metabolism by probiotic and prebiotic intake promotes short-chain fatty acid production in the gut microbiome: a randomized, double-blind, placebo-controlled crossover trial},
  journal = {Bioscience, Biotechnology, and Biochemistry},
  year = {2025},
  volume = {89},
  number = {8},
  pages = {1191--1202},
  doi = {10.1093/bbb/zbaf071}
}
Kostenlos starten →